We observed higher levels of TF on EVs from COVID-19 patients who experienced stroke, venous thromboembolism, splenic infarct, or vision changes due to hypercoagulability[11], consistent with previous findings showing an association of higher levels of EV-TF with venous thromboembolism[87,88]. Here, TF is linked to splenic infarction.